Target Name: NRSN2
NCBI ID: G80023
Review Report on NRSN2 Target / Biomarker Content of Review Report on NRSN2 Target / Biomarker
NRSN2
Other Name(s): Neurensin-2 (isoform 1) | NRSN2_HUMAN | Neurensin 2, transcript variant 1 | Neurensin-2 | NRSN2 variant 1 | C20orf98 | dJ1103G7.6 | neurensin 2

NRSN2: A Protein Involved in Neural Circuits and Potential Drug Targets

NRSN2 (Neurensin-2 (isoform 1)) is a protein that is expressed in various tissues of the brain, including the neuron, and is involved in the development and maintenance of neural circuits. The study of NRSN2 and its potential as a drug target or biomarker has become a topic of interest in the scientific community due to its unique biology and the potential it holds for the treatment of neurological disorders.

NRSN2 is a transmembrane protein that is characterized by its ability to interact with various signaling molecules, including cAMP, PKA, and CREB-1. These interactions are crucial for the regulation of neural circuits and are a key factor in the development and maintenance of neuronal plasticity.

One of the key functions of NRSN2 is its role in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt over time. NRSN2 has been shown to play a crucial role in the regulation of long-term potentiation (LTP) and long-term depression (LTD), which are important mechanisms that allow the brain to store and retain information.

In addition to its role in synaptic plasticity, NRSN2 has also been shown to be involved in the regulation of neurotransmitter release and cell survival. NRSN2 has been shown to interact with various neurotransmitter systems, including dopamine, GABA, and glutamate, and has been shown to play a role in the regulation of neurotransmitter release and cell survival.

The potential clinical applications of NRSN2 as a drug target or biomarker are vast. For example, NRSN2 has been shown to be involved in the development of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, NRSN2 has also been shown to be involved in the development of several psychiatric disorders, including depression and anxiety.

In addition to its potential clinical applications, NRSN2 also has significant potential as a research tool. The study of NRSN2 has led to a greater understanding of the biology of synaptic plasticity and has provided new insights into the regulation of neural circuits. Additionally, the study of NRSN2 has also led to the development of new technologies for the detection and manipulation of NRSN2, which has the potential to revolutionize the field of neuroscience.

In conclusion, NRSN2 is a protein that is involved in the development and maintenance of neural circuits and has significant potential as a drug target or biomarker. The study of NRSN2 has led to new insights into the regulation of synaptic plasticity and has the potential to revolutionize the field of neuroscience. Further research is needed to fully understand the role of NRSN2 in neural circuits and to develop new treatments based on its unique biology.

Protein Name: Neurensin 2

Functions: May play a role in maintenance and/or transport of vesicles

The "NRSN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRSN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3 | NSUN4 | NSUN5 | NSUN5P1 | NSUN5P2 | NSUN6 | NSUN7 | NT5C | NT5C1A | NT5C1B | NT5C1B-RDH14 | NT5C2 | NT5C3A | NT5C3AP1 | NT5C3B | NT5CP2 | NT5DC1 | NT5DC2 | NT5DC3 | NT5DC4 | NT5E | NT5M | NTAN1 | NTAQ1 | NTF3 | NTF4 | NTHL1 | NTM | NTMT1 | NTMT2 | NTN1 | NTN3 | NTN4 | NTN5 | NTNG1 | NTNG2 | NTPCR | NTRK1 | NTRK2 | NTRK3 | NTRK3-AS1 | NTS | NTSR1 | NTSR2 | NuA4 histone acetyltransferase (HAT) complex | NUAK Family SNF1-like Kinase (nonspcified subtype) | NUAK1 | NUAK2 | NUB1 | NUBP1 | NUBP2 | NUBPL | NUCB1 | NUCB2 | NUCKS1 | Nuclear factor interleukin-3-regulated protein-like | Nuclear factor of activated T-cells | Nuclear Pore Complex | Nuclear Receptor ROR | Nuclear transcription factor Y | Nucleoside Diphosphate Kinase (NDK) | Nucleosome Remodeling and Deacetylase (NuRD) Complex | Nucleosome-remodeling factor complex (NURF) | NUDC | NUDCD1 | NUDCD2 | NUDCD3 | NUDCP2 | NUDT1 | NUDT10 | NUDT11 | NUDT12